Comparative study of vaginal Misoprostol tablet versus Dinoprostone insert in induction of labor

"Comparative study of vaginal Misoprostol tablet versus Dinoprostone insert in induction of labor"

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059802

Enrollment

106

Registered

2023-11-14

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Misoprostol 25mcg tablet: Multiple tablets can be used to a maximum of of 200mcg Route of administration is per vaginum Reassessment every 4th hourly until active labour is start at 4cm

Eligibility

Inclusion criteria

Inclusion criteria: 1)Singleton 2)Term pregnancy ( >37 WEEKS) 3)Maternal or fetal indication of induction of labour 4)Cephalic presentation 5)Intact membranes 6)Bishop score 7)reassuring fetal heart rate

Exclusion criteria

Exclusion criteria: All contraindications to vaginal delivery - 1)Placenta previa or vasa previa 2)Surgical procdures on uterine body (Previous lscs,Intrapartum uterine rupture and myomectomy) 3)Invasive cancer of cervix 4)Active genital herpes infection 5)Malpresentations and malpositions 6)Premature rupture of membranes

Design outcomes

Primary

Measure	Time frame
To study the effect of drugs in induction of labour and how it helps in progression of labourTimepoint: 24hrs	—

Secondary

Measure	Time frame
To compare the safety & efficacy of the two drugs involved in terms of fetal & maternal outcomesTimepoint: 24hrs	—

Countries

India

Contacts

Public ContactDR SUBHASHCHANDRA R MUDANUR

SHRI B.M PATIL MEDICAL COLLEGE AND HOSPITAL

drmudanurs@gmail.com9448820961

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026